
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xml:lang="en-US"
               >
      <channel>
        <title>Latest articles from MPR Clinical Charts</title>
        <link>http://feeds2.feedburner.com/mprclinicalcharts</link>
        <description>Latest articles from MPR Clinical Charts</description>
        
          <itunes:author><![CDATA[MPR]]></itunes:author>
        <itunes:subtitle>Clinical Charts</itunes:subtitle>
        <itunes:summary><![CDATA[Clinical charts and treatment protocols for numerous therapeutic diseases and disorders such as cardiovascular, oncology, neurological and many more. Download our FREE app now.
]]></itunes:summary>
        <itunes:owner>
            <itunes:name>Clinical Charts</itunes:name>
            <itunes:email>custserv@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="Business">
            <itunes:category text="Business News" /> 
        </itunes:category> 
        <itunes:image href='https://media.empr.com/images/2009/12/22/mpr_mobile_83145.png'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
          
          <atom:link href="http://feeds2.feedburner.com/mprclinicalcharts" rel="self" type="application/rss+xml" />
  
        <item>
          
          <title>Antiretroviral Lab Monitoring</title>
            
            
            <description>Laboratory monitoring schedule for patients before and after initiation of antiretroviral therapy.</description>
            
            <link>https://www.empr.com/antiretroviral-lab-monitoring/article/291769/</link>
            <pubDate>Tue, 05 Feb 2019 21:30:00 GMT</pubDate>
            
          <itunes:summary>Laboratory monitoring schedule for patients before and after initiation of antiretroviral therapy.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/antiretroviral-lab-monitoring/article/291769/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Dementia Management</title>
            
            
            <description>Dementia care practice recommendations for assisted living residences and nursing homes chart.</description>
            
            <link>https://www.empr.com/dementia-management/article/123645/</link>
            <pubDate>Fri, 25 Jan 2019 19:00:00 GMT</pubDate>
            
          <itunes:summary>Dementia care practice recommendations for assisted living residences and nursing homes chart.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/dementia-management/article/123645/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Community Acquired Pneumonia Guidelines</title>
            
            
            <description>Diagnose, treat, and prevent community acquired pneumonia using key recommendations from the IDSA/ATS CAP guidelines.</description>
            
            <link>https://www.empr.com/community-acquired-pneumonia-guidelines/article/321826/</link>
            <pubDate>Fri, 25 Jan 2019 18:30:00 GMT</pubDate>
            
          <itunes:summary>Diagnose, treat, and prevent community acquired pneumonia using key recommendations from the IDSA/ATS CAP guidelines.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/community-acquired-pneumonia-guidelines/article/321826/</guid>
               
                                
        </item>
  
        <item>
          
          <title>HIV Postexposure Prophylaxis Algorithm: Occupational Exposure</title>
            
            
            <description>Criteria for recommending postexposure prophylaxis (PEP) to HIV following occupational exposure</description>
            
            <link>https://www.empr.com/hiv-postexposure-prophylaxis-algorithm-occupational-exposure/article/158622/</link>
            <pubDate>Fri, 25 Jan 2019 18:30:00 GMT</pubDate>
            
          <itunes:summary>Criteria for recommending postexposure prophylaxis (PEP) to HIV following occupational exposure</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hiv-postexposure-prophylaxis-algorithm-occupational-exposure/article/158622/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Sexually Transmitted Diseases Treatment Guidelines</title>
            
            
            <description>Summary of the 2015 CDC Treatment Guidelines for Sexually Transmitted Diseases</description>
            
            <link>https://www.empr.com/sexually-transmitted-diseases-treatment-guidelines/article/478779/</link>
            <pubDate>Fri, 25 Jan 2019 18:00:00 GMT</pubDate>
            
          <itunes:summary>Summary of the 2015 CDC Treatment Guidelines for Sexually Transmitted Diseases</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/sexually-transmitted-diseases-treatment-guidelines/article/478779/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Antiretroviral Adherence Strategies</title>
            
            
            <description>Strategies to improve adherence to antiretroviral treatments.</description>
            
            <link>https://www.empr.com/antiretroviral-adherence-strategies/article/291766/</link>
            <pubDate>Thu, 10 Jan 2019 14:30:00 GMT</pubDate>
            
          <itunes:summary>Strategies to improve adherence to antiretroviral treatments.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/antiretroviral-adherence-strategies/article/291766/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Guidelines for Vaccinating Pregnant Women</title>
            
            
            <description>Special recommendations and contraindications for vaccinating pregnant woman.</description>
            
            <link>https://www.empr.com/guidelines-for-vaccinating-pregnant-women/article/124013/</link>
            <pubDate>Wed, 09 Jan 2019 18:30:00 GMT</pubDate>
            
          <itunes:summary>Special recommendations and contraindications for vaccinating pregnant woman.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/guidelines-for-vaccinating-pregnant-women/article/124013/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Diabetes Treatments</title>
            
            
            <description>Antidiabetic agents for the treatment of diabetes including maintenance and max doses.</description>
            
            <link>https://www.empr.com/diabetes-treatments/article/123836/</link>
            <pubDate>Mon, 07 Jan 2019 18:30:00 GMT</pubDate>
            
          <itunes:summary>Antidiabetic agents for the treatment of diabetes including maintenance and max doses.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/diabetes-treatments/article/123836/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Erectile Dysfunction Treatments</title>
            
            
            <description>Erectile dysfunction treatment chart including onset time, duration of action, and dosing for each drug product.</description>
            
            <link>https://www.empr.com/erectile-dysfunction-treatments/article/125874/</link>
            <pubDate>Mon, 07 Jan 2019 17:30:00 GMT</pubDate>
            
          <itunes:summary>Erectile dysfunction treatment chart including onset time, duration of action, and dosing for each drug product.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/erectile-dysfunction-treatments/article/125874/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Anticoagulant Dosing Conversions</title>
            
            
            <description>Recommended dosing conversions for anticoagulants such as warfarin, heparin, and dabigatran.</description>
            
            <link>https://www.empr.com/anticoagulant-dosing-conversions/article/194271/</link>
            <pubDate>Mon, 07 Jan 2019 17:00:00 GMT</pubDate>
            
          <itunes:summary>Recommended dosing conversions for anticoagulants such as warfarin, heparin, and dabigatran.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/anticoagulant-dosing-conversions/article/194271/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Benign Prostatic Hyperplasia Treatments</title>
            
            
            <description>Benign prostatic hyperplasia (BPH) treatment chart including drug dosing, formulation, strength, and pharmacological class.</description>
            
            <link>https://www.empr.com/benign-prostatic-hyperplasia-treatments/article/125877/</link>
            <pubDate>Mon, 07 Jan 2019 17:00:00 GMT</pubDate>
            
          <itunes:summary>Benign prostatic hyperplasia (BPH) treatment chart including drug dosing, formulation, strength, and pharmacological class.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/benign-prostatic-hyperplasia-treatments/article/125877/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Exams/Tests Needed Before Contraceptive Initiation</title>
            
            
            <description>Exams or tests needed prior to initiating a contraceptive method such as IUDs, combined hormonal contraceptives and progestin-only pills.</description>
            
            <link>https://www.empr.com/examstests-needed-before-contraceptive-initiation/article/300660/</link>
            <pubDate>Mon, 07 Jan 2019 17:00:00 GMT</pubDate>
            
          <itunes:summary>Exams or tests needed prior to initiating a contraceptive method such as IUDs, combined hormonal contraceptives and progestin-only pills.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/examstests-needed-before-contraceptive-initiation/article/300660/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Gout Treatments</title>
            
            
            <description>Gout treatment chart for acute attacks or chronic management/prevention.</description>
            
            <link>https://www.empr.com/gout-treatments/article/123616/</link>
            <pubDate>Mon, 07 Jan 2019 17:00:00 GMT</pubDate>
            
          <itunes:summary>Gout treatment chart for acute attacks or chronic management/prevention.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/gout-treatments/article/123616/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Psychosis Treatments</title>
            
            
            <description>A comparative dosing and titration chart of commonly used first-generation and second-generation antipsychotics.</description>
            
            <link>https://www.empr.com/psychosis-treatments/article/197121/</link>
            <pubDate>Mon, 07 Jan 2019 16:00:00 GMT</pubDate>
            
          <itunes:summary>A comparative dosing and titration chart of commonly used first-generation and second-generation antipsychotics.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/psychosis-treatments/article/197121/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Psychotropic Drug Indications</title>
            
            
            <description>A comparative list of psychotropic medications with their mood disorder indications (bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others).</description>
            
            <link>https://www.empr.com/psychotropic-drug-indications/article/123832/</link>
            <pubDate>Mon, 07 Jan 2019 16:00:00 GMT</pubDate>
            
          <itunes:summary>A comparative list of psychotropic medications with their mood disorder indications (bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others).</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/psychotropic-drug-indications/article/123832/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Antiepileptic Drug Indications</title>
            
            
            <description>Comparative chart of antiepileptic drugs (AEDs) and their seizure/epilepsy indications.</description>
            
            <link>https://www.empr.com/antiepileptic-drug-indications/article/796073/</link>
            <pubDate>Mon, 07 Jan 2019 15:00:00 GMT</pubDate>
            
          <itunes:summary>Comparative chart of antiepileptic drugs (AEDs) and their seizure/epilepsy indications.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/antiepileptic-drug-indications/article/796073/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Psoriasis Treatments</title>
            
            
            <description>Systemic therapy treatment chart for psoriasis patients generally reserved for those with chronic plaque psoriasis without psoriatic arthritis who are candidates for systemic treatment when UV therapy is not available.</description>
            
            <link>https://www.empr.com/psoriasis-treatments/article/209229/</link>
            <pubDate>Mon, 07 Jan 2019 14:00:00 GMT</pubDate>
            
          <itunes:summary>Systemic therapy treatment chart for psoriasis patients generally reserved for those with chronic plaque psoriasis without psoriatic arthritis who are candidates for systemic treatment when UV therapy is not available.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/psoriasis-treatments/article/209229/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Ulcerative Colitis Treatments</title>
            
            
            <description>Medications for the treatment, induction of remission, and maintenance of ulcerative colitis.</description>
            
            <link>https://www.empr.com/ulcerative-colitis-treatments/article/368656/</link>
            <pubDate>Mon, 07 Jan 2019 14:00:00 GMT</pubDate>
            
          <itunes:summary>Medications for the treatment, induction of remission, and maintenance of ulcerative colitis.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/ulcerative-colitis-treatments/article/368656/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Opioid-Induced Constipation Management Guidelines</title>
            
            
            <description>Recommendations from the American Gastroenterological Association (AGA) for the medical management of opioid-induced constipation (OIC).</description>
            
            <link>https://www.empr.com/opioid-induced-constipation-management-guidelines/article/823752/</link>
            <pubDate>Thu, 27 Dec 2018 20:37:01 GMT</pubDate>
            
          <itunes:summary>Recommendations from the American Gastroenterological Association (AGA) for the medical management of opioid-induced constipation (OIC).</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/opioid-induced-constipation-management-guidelines/article/823752/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Arthritis Treatments: DMARDS and Other Immune Modulators</title>
            
            
            <description>A comparative list of treatment options for arthritis including DMARDS and other immune modulators.</description>
            
            <link>https://www.empr.com/arthritis-treatments-dmards-and-other-immune-modulators/article/193565/</link>
            <pubDate>Wed, 26 Dec 2018 22:30:00 GMT</pubDate>
            
          <itunes:summary>A comparative list of treatment options for arthritis including DMARDS and other immune modulators.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/arthritis-treatments-dmards-and-other-immune-modulators/article/193565/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Antiretroviral Treatments</title>
            
            
            <description>A list of treatment options for HIV infection.</description>
            
            <link>https://www.empr.com/antiretroviral-treatments/article/158627/</link>
            <pubDate>Wed, 26 Dec 2018 20:30:00 GMT</pubDate>
            
          <itunes:summary>A list of treatment options for HIV infection.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/antiretroviral-treatments/article/158627/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Antiretroviral Formulations</title>
            
            
            <description>A comparative list of antiretroviral drug formulations by class (NNRTIs, NRTIs, protease inhibitors, entry/fusion inhibitors, integrase inhibitors, PK enhancer, fixed-dose combination) for HIV-1 infection.</description>
            
            <link>https://www.empr.com/antiretroviral-formulations/article/130345/</link>
            <pubDate>Wed, 26 Dec 2018 19:00:00 GMT</pubDate>
            
          <itunes:summary>A comparative list of antiretroviral drug formulations by class (NNRTIs, NRTIs, protease inhibitors, entry/fusion inhibitors, integrase inhibitors, PK enhancer, fixed-dose combination) for HIV-1 infection.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/antiretroviral-formulations/article/130345/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Antiretroviral Contraindications and Drug Interactions</title>
            
            
            <description>A list of contraindications and drug interactions for HIV medications.</description>
            
            <link>https://www.empr.com/antiretroviral-contraindications-and-drug-interactions/article/158625/</link>
            <pubDate>Wed, 26 Dec 2018 18:00:00 GMT</pubDate>
            
          <itunes:summary>A list of contraindications and drug interactions for HIV medications.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/antiretroviral-contraindications-and-drug-interactions/article/158625/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Bleeding Disorder Treatments: Hemophilia A</title>
            
            
            <description>Treatment options for Hemophilia A including factors and other biologics.</description>
            
            <link>https://www.empr.com/bleeding-disorder-treatments-hemophilia-a/article/771638/</link>
            <pubDate>Fri, 21 Dec 2018 16:30:00 GMT</pubDate>
            
          <itunes:summary>Treatment options for Hemophilia A including factors and other biologics.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/bleeding-disorder-treatments-hemophilia-a/article/771638/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Thromboembolic Disorder Treatments: Without DVT/PE</title>
            
            
            <description>A comparative medication chart of thromboembolic disorder treatments in patients without DVT/PE.</description>
            
            <link>https://www.empr.com/thromboembolic-disorder-treatments-without-dvtpe/article/207380/</link>
            <pubDate>Fri, 21 Dec 2018 15:30:00 GMT</pubDate>
            
          <itunes:summary>A comparative medication chart of thromboembolic disorder treatments in patients without DVT/PE.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/thromboembolic-disorder-treatments-without-dvtpe/article/207380/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Risk Factors for Overactive Bladder and Urinary Incontinence</title>
            
            
            <description>Risk factors for overactive bladder and urinary incontinence chart in men and women.</description>
            
            <link>https://www.empr.com/risk-factors-for-overactive-bladder-and-urinary-incontinence/article/125881/</link>
            <pubDate>Tue, 11 Dec 2018 21:00:00 GMT</pubDate>
            
          <itunes:summary>Risk factors for overactive bladder and urinary incontinence chart in men and women.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/risk-factors-for-overactive-bladder-and-urinary-incontinence/article/125881/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Alzheimer&apos;s Dementia Treatments</title>
            
            
            <description>A list of medications comparing Alzheimer&apos;s Dementia treatments.</description>
            
            <link>https://www.empr.com/alzheimers-dementia-treatments/article/123639/</link>
            <pubDate>Tue, 11 Dec 2018 20:00:00 GMT</pubDate>
            
          <itunes:summary>A list of medications comparing Alzheimer&apos;s Dementia treatments.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/alzheimers-dementia-treatments/article/123639/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Chronic Obstructive Pulmonary Disease Treatments</title>
            
            
            <description>List of FDA-approved medications used for the maintenance and treatment of chronic obstructive pulmonary disease (COPD).</description>
            
            <link>https://www.empr.com/chronic-obstructive-pulmonary-disease-treatments/article/216550/</link>
            <pubDate>Tue, 11 Dec 2018 20:00:00 GMT</pubDate>
            
          <itunes:summary>List of FDA-approved medications used for the maintenance and treatment of chronic obstructive pulmonary disease (COPD).</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/chronic-obstructive-pulmonary-disease-treatments/article/216550/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Androgens</title>
            
            
            <description>Androgens used for testosterone replacement therapy organized by route of administration chart.</description>
            
            <link>https://www.empr.com/androgens/article/125875/</link>
            <pubDate>Tue, 11 Dec 2018 19:00:00 GMT</pubDate>
            
          <itunes:summary>Androgens used for testosterone replacement therapy organized by route of administration chart.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/androgens/article/125875/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Insulins</title>
            
            
            <description>Types of insulins categorized by their pharmacodynamic properties.</description>
            
            <link>https://www.empr.com/insulins/article/123739/</link>
            <pubDate>Tue, 11 Dec 2018 16:30:00 GMT</pubDate>
            
          <itunes:summary>Types of insulins categorized by their pharmacodynamic properties.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/insulins/article/123739/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Multiple Sclerosis Guidelines: Disease-Modifying Therapy</title>
            
            
            <description>Recommendations for the use of disease-modifying therapies (DMT) in adults with multiple sclerosis (MS) from the American Academy of Neurology.</description>
            
            <link>https://www.empr.com/multiple-sclerosis-guidelines-disease-modifying-therapy/article/818764/</link>
            <pubDate>Tue, 04 Dec 2018 19:00:44 GMT</pubDate>
            
          <itunes:summary>Recommendations for the use of disease-modifying therapies (DMT) in adults with multiple sclerosis (MS) from the American Academy of Neurology.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/multiple-sclerosis-guidelines-disease-modifying-therapy/article/818764/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Migraine and Headache Treatments</title>
            
            
            <description>Adult doses for migraine and headache treatments including barbiturates, ergot alkaloids, and NSAIDs.</description>
            
            <link>https://www.empr.com/migraine-and-headache-treatments/article/169358/</link>
            <pubDate>Mon, 03 Dec 2018 15:30:00 GMT</pubDate>
            
          <itunes:summary>Adult doses for migraine and headache treatments including barbiturates, ergot alkaloids, and NSAIDs.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/migraine-and-headache-treatments/article/169358/</guid>
               
                                
        </item>
  
        <item>
          
          <title>FDA-Approved Non-Small Cell Lung Cancer (NSCLC) Treatments</title>
            
            
            <description>Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).</description>
            
            <link>https://www.empr.com/fda-approved-non-small-cell-lung-cancer-nsclc-treatments/article/123617/</link>
            <pubDate>Mon, 03 Dec 2018 15:00:00 GMT</pubDate>
            
          <itunes:summary>Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/fda-approved-non-small-cell-lung-cancer-nsclc-treatments/article/123617/</guid>
               
                                
        </item>
  
        <item>
          
          <title>FDA-Approved Colorectal Cancer Treatments</title>
            
            
            <description>Colorectal cancer treatment regimen chart.</description>
            
            <link>https://www.empr.com/fda-approved-colorectal-cancer-treatments/article/123366/</link>
            <pubDate>Mon, 03 Dec 2018 14:30:00 GMT</pubDate>
            
          <itunes:summary>Colorectal cancer treatment regimen chart.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/fda-approved-colorectal-cancer-treatments/article/123366/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Rhinitis &amp; Nasal Congestion Treatments</title>
            
            
            <description>Rhinitis &amp; nasal congestion chart of prescription and over-the-counter (OTC) drugs.</description>
            
            <link>https://www.empr.com/rhinitis-nasal-congestion-treatments/article/253097/</link>
            <pubDate>Thu, 29 Nov 2018 21:30:00 GMT</pubDate>
            
          <itunes:summary>Rhinitis &amp; nasal congestion chart of prescription and over-the-counter (OTC) drugs.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/rhinitis-nasal-congestion-treatments/article/253097/</guid>
               
                                
        </item>
  
        <item>
          
          <title>FDA-Approved Breast Cancer Treatments</title>
            
            
            <description>FDA-approved oral and injectable treatment options for breast cancer.</description>
            
            <link>https://www.empr.com/fda-approved-breast-cancer-treatments/article/123364/</link>
            <pubDate>Thu, 29 Nov 2018 18:00:00 GMT</pubDate>
            
          <itunes:summary>FDA-approved oral and injectable treatment options for breast cancer.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/fda-approved-breast-cancer-treatments/article/123364/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Parkinsonism Treatments</title>
            
            
            <description>Parkinson&apos;s drug treatment chart categorized by pharmacological class.</description>
            
            <link>https://www.empr.com/parkinsonism-treatments/article/123649/</link>
            <pubDate>Thu, 29 Nov 2018 17:00:00 GMT</pubDate>
            
          <itunes:summary>Parkinson&apos;s drug treatment chart categorized by pharmacological class.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/parkinsonism-treatments/article/123649/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Thromboembolic Disorder Treatments: DVT/PE</title>
            
            
            <description>List of medications indicated for the prophylaxis and/or treatment of deep vein thrombosis (DVT) / pulmonary embolism (PE) with usual adult dosage.</description>
            
            <link>https://www.empr.com/thromboembolic-disorder-treatments-dvtpe/article/219928/</link>
            <pubDate>Wed, 28 Nov 2018 23:30:00 GMT</pubDate>
            
          <itunes:summary>List of medications indicated for the prophylaxis and/or treatment of deep vein thrombosis (DVT) / pulmonary embolism (PE) with usual adult dosage.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/thromboembolic-disorder-treatments-dvtpe/article/219928/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Bleeding Disorder Treatments: Hemophilia B</title>
            
            
            <description>Treatment options for Hemophilia B.</description>
            
            <link>https://www.empr.com/bleeding-disorder-treatments-hemophilia-b/article/772277/</link>
            <pubDate>Wed, 28 Nov 2018 23:00:00 GMT</pubDate>
            
          <itunes:summary>Treatment options for Hemophilia B.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/bleeding-disorder-treatments-hemophilia-b/article/772277/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Bowel Cleansers</title>
            
            
            <description>Bowel cleansing products comparison chart (hyperosmotics, isosmotics, isosmotic/stimulant laxative combinations, osmotics) used for colonoscopy preparation.</description>
            
            <link>https://www.empr.com/bowel-cleansers/article/165905/</link>
            <pubDate>Wed, 28 Nov 2018 21:30:00 GMT</pubDate>
            
          <itunes:summary>Bowel cleansing products comparison chart (hyperosmotics, isosmotics, isosmotic/stimulant laxative combinations, osmotics) used for colonoscopy preparation.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/bowel-cleansers/article/165905/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hypertension Treatments: Oral CCBs</title>
            
            
            <description>Oral calcium channel blockers (CCBs) for the treatment of hypertension including benzothiazepines, dihydropyridines, and diphenylalkylamines.</description>
            
            <link>https://www.empr.com/hypertension-treatments-oral-ccbs/article/221241/</link>
            <pubDate>Wed, 28 Nov 2018 21:00:00 GMT</pubDate>
            
          <itunes:summary>Oral calcium channel blockers (CCBs) for the treatment of hypertension including benzothiazepines, dihydropyridines, and diphenylalkylamines.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hypertension-treatments-oral-ccbs/article/221241/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hypertension Treatments: ARBs</title>
            
            
            <description>A comparative list of Angiotensin II Receptor Blockers (ARBs) monotherapy and combination therapy for the treatment of hypertension.</description>
            
            <link>https://www.empr.com/hypertension-treatments-arbs/article/221238/</link>
            <pubDate>Wed, 28 Nov 2018 20:30:00 GMT</pubDate>
            
          <itunes:summary>A comparative list of Angiotensin II Receptor Blockers (ARBs) monotherapy and combination therapy for the treatment of hypertension.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hypertension-treatments-arbs/article/221238/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Narcotic Analgesics</title>
            
            
            <description>A comparative chart of narcotic analgesics including formulations, strengths, and dosing intervals.</description>
            
            <link>https://www.empr.com/narcotic-analgesics/article/123833/</link>
            <pubDate>Wed, 28 Nov 2018 19:30:00 GMT</pubDate>
            
          <itunes:summary>A comparative chart of narcotic analgesics including formulations, strengths, and dosing intervals.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/narcotic-analgesics/article/123833/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Vaginal Infection Treatments</title>
            
            
            <description>Oral and topical vaginal infection treatment options for vulvovaginal candidiasis and bacterial vaginosis.</description>
            
            <link>https://www.empr.com/vaginal-infection-treatments/article/124020/</link>
            <pubDate>Wed, 28 Nov 2018 18:00:00 GMT</pubDate>
            
          <itunes:summary>Oral and topical vaginal infection treatment options for vulvovaginal candidiasis and bacterial vaginosis.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/vaginal-infection-treatments/article/124020/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hormone Replacement Therapies</title>
            
            
            <description>Chart with different formulations and combination of drugs used to treat menopause.</description>
            
            <link>https://www.empr.com/hormone-replacement-therapies/article/123738/</link>
            <pubDate>Wed, 28 Nov 2018 17:30:00 GMT</pubDate>
            
          <itunes:summary>Chart with different formulations and combination of drugs used to treat menopause.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hormone-replacement-therapies/article/123738/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hypertension Treatments: ACE Inhibitors</title>
            
            
            <description>A comparative list of Angiotensin-Converting Enzyme (ACE) Inhibitors monotherapy and combination therapy for the treatment of hypertension.</description>
            
            <link>https://www.empr.com/hypertension-treatments-ace-inhibitors/article/221239/</link>
            <pubDate>Wed, 21 Nov 2018 14:30:00 GMT</pubDate>
            
          <itunes:summary>A comparative list of Angiotensin-Converting Enzyme (ACE) Inhibitors monotherapy and combination therapy for the treatment of hypertension.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hypertension-treatments-ace-inhibitors/article/221239/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Dyslipidemia Drug Indications</title>
            
            
            <description>Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.</description>
            
            <link>https://www.empr.com/dyslipidemia-drug-indications/article/123682/</link>
            <pubDate>Tue, 13 Nov 2018 16:30:00 GMT</pubDate>
            
          <itunes:summary>Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/dyslipidemia-drug-indications/article/123682/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Combination Hypertension Treatments</title>
            
            
            <description>A comparative list of combination antihypertensive medications.</description>
            
            <link>https://www.empr.com/combination-hypertension-treatments/article/191718/</link>
            <pubDate>Tue, 13 Nov 2018 16:00:00 GMT</pubDate>
            
          <itunes:summary>A comparative list of combination antihypertensive medications.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/combination-hypertension-treatments/article/191718/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Oral Urinary Tract Infection Treatments</title>
            
            
            <description>Oral antibiotics for urinary tract infections (UTIs) treatment chart including dosing and duration.</description>
            
            <link>https://www.empr.com/oral-urinary-tract-infection-treatments/article/125880/</link>
            <pubDate>Mon, 29 Oct 2018 17:30:00 GMT</pubDate>
            
          <itunes:summary>Oral antibiotics for urinary tract infections (UTIs) treatment chart including dosing and duration.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/oral-urinary-tract-infection-treatments/article/125880/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Overactive Bladder &amp; Urinary Incontinence Treatments</title>
            
            
            <description>Overactive bladder and urinary incontinence dosing regimen chart for anticholinergics, antispasmodic/anticholinergics, muscarinic antagonists, and synthetic vasopressin.</description>
            
            <link>https://www.empr.com/overactive-bladder-urinary-incontinence-treatments/article/128720/</link>
            <pubDate>Mon, 29 Oct 2018 16:30:00 GMT</pubDate>
            
          <itunes:summary>Overactive bladder and urinary incontinence dosing regimen chart for anticholinergics, antispasmodic/anticholinergics, muscarinic antagonists, and synthetic vasopressin.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/overactive-bladder-urinary-incontinence-treatments/article/128720/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Acute Otitis Media Treatments</title>
            
            
            <description>Acute otitis media treatment chart including select antibiotics and recommended doses.</description>
            
            <link>https://www.empr.com/acute-otitis-media-treatments/article/125853/</link>
            <pubDate>Mon, 29 Oct 2018 15:30:00 GMT</pubDate>
            
          <itunes:summary>Acute otitis media treatment chart including select antibiotics and recommended doses.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/acute-otitis-media-treatments/article/125853/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Antifungal Formulations</title>
            
            
            <description>List of different formulations (eg, tablets, capsules, liquids, topicals, injections, etc) available for the various prescription and over-the-counter antifungal therapies.</description>
            
            <link>https://www.empr.com/antifungal-formulations/article/642424/</link>
            <pubDate>Fri, 26 Oct 2018 19:30:00 GMT</pubDate>
            
          <itunes:summary>List of different formulations (eg, tablets, capsules, liquids, topicals, injections, etc) available for the various prescription and over-the-counter antifungal therapies.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/antifungal-formulations/article/642424/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Antibiotic Formulations</title>
            
            
            <description>Antibiotic formulation (tablets, capsules, liquids, inhalations or injection) chart.</description>
            
            <link>https://www.empr.com/antibiotic-formulations/article/123670/</link>
            <pubDate>Fri, 26 Oct 2018 19:00:00 GMT</pubDate>
            
          <itunes:summary>Antibiotic formulation (tablets, capsules, liquids, inhalations or injection) chart.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/antibiotic-formulations/article/123670/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Oral Acne Treatments</title>
            
            
            <description>Oral medications for the treatment of acne including dosing for antibiotics, retinoids, and contraceptives.</description>
            
            <link>https://www.empr.com/oral-acne-treatments/article/300097/</link>
            <pubDate>Fri, 26 Oct 2018 18:30:00 GMT</pubDate>
            
          <itunes:summary>Oral medications for the treatment of acne including dosing for antibiotics, retinoids, and contraceptives.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/oral-acne-treatments/article/300097/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hypertension Treatments: Diuretics</title>
            
            
            <description>A comparative list of loop, potassium-sparing, and thiazide-like diuretics monotherapy and combination therapy for the treatment of hypertension.</description>
            
            <link>https://www.empr.com/hypertension-treatments-diuretics/article/221242/</link>
            <pubDate>Thu, 25 Oct 2018 20:00:00 GMT</pubDate>
            
          <itunes:summary>A comparative list of loop, potassium-sparing, and thiazide-like diuretics monotherapy and combination therapy for the treatment of hypertension.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hypertension-treatments-diuretics/article/221242/</guid>
               
                                
        </item>
  
        <item>
          
          <title>GERD Diagnosis and Management Guidelines</title>
            
            
            <description>Expert recommendations for the diagnosis and management of gastroesophageal reflux disease (GERD).</description>
            
            <link>https://www.empr.com/gerd-diagnosis-and-management-guidelines/article/806222/</link>
            <pubDate>Tue, 09 Oct 2018 20:25:10 GMT</pubDate>
            
          <itunes:summary>Expert recommendations for the diagnosis and management of gastroesophageal reflux disease (GERD).</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/gerd-diagnosis-and-management-guidelines/article/806222/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Insulin Administration</title>
            
            
            <description>Insulin preparations categorized by rapid-, short-, intermediate- and long-acting. Information such as the route, administration as well as the mixing of insulins is provided.</description>
            
            <link>https://www.empr.com/insulin-administration/article/123646/</link>
            <pubDate>Thu, 04 Oct 2018 14:30:00 GMT</pubDate>
            
          <itunes:summary>Insulin preparations categorized by rapid-, short-, intermediate- and long-acting. Information such as the route, administration as well as the mixing of insulins is provided.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/insulin-administration/article/123646/</guid>
               
                                
        </item>
  
        <item>
          
          <title>FDA-Approved Prostate Cancer Treatments</title>
            
            
            <description>Approved prostate cancer drug treatments including formulations and usual dosing.</description>
            
            <link>https://www.empr.com/fda-approved-prostate-cancer-treatments/article/123619/</link>
            <pubDate>Tue, 02 Oct 2018 14:00:00 GMT</pubDate>
            
          <itunes:summary>Approved prostate cancer drug treatments including formulations and usual dosing.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/fda-approved-prostate-cancer-treatments/article/123619/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Emetogenic Potential of Antineoplastic Agents</title>
            
            
            <description>Emetogenic potential (high, moderate, low, or minimal risk) of oral and injectable antineoplastic agents.</description>
            
            <link>https://www.empr.com/emetogenic-potential-of-antineoplastic-agents/article/123615/</link>
            <pubDate>Tue, 02 Oct 2018 13:00:00 GMT</pubDate>
            
          <itunes:summary>Emetogenic potential (high, moderate, low, or minimal risk) of oral and injectable antineoplastic agents.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/emetogenic-potential-of-antineoplastic-agents/article/123615/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Influenza Vaccine Dosing Algorithm: 6 Months-8 Years</title>
            
            
            <description>Influenza vaccine dosing algorithm for children 6 months to 8 years of age.</description>
            
            <link>https://www.empr.com/influenza-vaccine-dosing-algorithm-6-months-8-years/article/318319/</link>
            <pubDate>Fri, 28 Sep 2018 17:00:00 GMT</pubDate>
            
          <itunes:summary>Influenza vaccine dosing algorithm for children 6 months to 8 years of age.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/influenza-vaccine-dosing-algorithm-6-months-8-years/article/318319/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Glaucoma Treatments</title>
            
            
            <description>Glaucoma treatment chart (alpha2-agonists, beta blockers, carbonic anhydrase inhibitors, cholinergic agonists, prostaglandin analogs).</description>
            
            <link>https://www.empr.com/glaucoma-treatments/article/180363/</link>
            <pubDate>Thu, 27 Sep 2018 17:30:00 GMT</pubDate>
            
          <itunes:summary>Glaucoma treatment chart (alpha2-agonists, beta blockers, carbonic anhydrase inhibitors, cholinergic agonists, prostaglandin analogs).</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/glaucoma-treatments/article/180363/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Multiple Sclerosis Treatments</title>
            
            
            <description>Inclusive list of disease modifying medications FDA approved for multiple sclerosis.</description>
            
            <link>https://www.empr.com/multiple-sclerosis-treatments/article/338818/</link>
            <pubDate>Thu, 27 Sep 2018 17:00:00 GMT</pubDate>
            
          <itunes:summary>Inclusive list of disease modifying medications FDA approved for multiple sclerosis.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/multiple-sclerosis-treatments/article/338818/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Influenza Vaccine Recommendations: Egg Allergies</title>
            
            
            <description>Influenza vaccine recommendations for individuals who report an allergy to eggs.</description>
            
            <link>https://www.empr.com/influenza-vaccine-recommendations-egg-allergies/article/318320/</link>
            <pubDate>Thu, 27 Sep 2018 16:30:00 GMT</pubDate>
            
          <itunes:summary>Influenza vaccine recommendations for individuals who report an allergy to eggs.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/influenza-vaccine-recommendations-egg-allergies/article/318320/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Influenza Vaccine Comparisons</title>
            
            
            <description>Compare and contrast influenza vaccines currently available for the 2018-2019 flu season including indicated ages, allergies, and how supplied.</description>
            
            <link>https://www.empr.com/influenza-vaccine-comparisons/article/307076/</link>
            <pubDate>Thu, 27 Sep 2018 15:00:00 GMT</pubDate>
            
          <itunes:summary>Compare and contrast influenza vaccines currently available for the 2018-2019 flu season including indicated ages, allergies, and how supplied.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/influenza-vaccine-comparisons/article/307076/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Irritable Bowel Syndrome Treatments</title>
            
            
            <description>Drug therapy for the treatment of irritable bowel syndrome (IBS).</description>
            
            <link>https://www.empr.com/irritable-bowel-syndrome-treatments/article/166496/</link>
            <pubDate>Thu, 27 Sep 2018 14:00:00 GMT</pubDate>
            
          <itunes:summary>Drug therapy for the treatment of irritable bowel syndrome (IBS).</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/irritable-bowel-syndrome-treatments/article/166496/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Antiemetic Treatments</title>
            
            
            <description>Antiemetic treatment chart including drug formulations, strengths, and usual doses for nausea/vomiting.</description>
            
            <link>https://www.empr.com/antiemetic-treatments/article/125873/</link>
            <pubDate>Wed, 26 Sep 2018 21:00:00 GMT</pubDate>
            
          <itunes:summary>Antiemetic treatment chart including drug formulations, strengths, and usual doses for nausea/vomiting.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/antiemetic-treatments/article/125873/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Oral Allergy Treatments: Rx</title>
            
            
            <description>A comparative dosing chart of prescription only oral medications for allergy treatment.</description>
            
            <link>https://www.empr.com/oral-allergy-treatments-rx/article/169356/</link>
            <pubDate>Wed, 26 Sep 2018 19:30:00 GMT</pubDate>
            
          <itunes:summary>A comparative dosing chart of prescription only oral medications for allergy treatment.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/oral-allergy-treatments-rx/article/169356/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Irritable Bowel Syndrome Evaluation</title>
            
            
            <description>Irritable Bowel Syndrome (IBS) evaluation chart based on Manning Criteria and Rome III Diagnostic Criteria.</description>
            
            <link>https://www.empr.com/irritable-bowel-syndrome-evaluation/article/167696/</link>
            <pubDate>Wed, 26 Sep 2018 17:00:00 GMT</pubDate>
            
          <itunes:summary>Irritable Bowel Syndrome (IBS) evaluation chart based on Manning Criteria and Rome III Diagnostic Criteria.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/irritable-bowel-syndrome-evaluation/article/167696/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Confused Drug Names</title>
            
            
            <description>Confused Drug Names according to ISMP guidelines chart</description>
            
            <link>https://www.empr.com/confused-drug-names/article/259474/</link>
            <pubDate>Fri, 31 Aug 2018 16:30:00 GMT</pubDate>
            
          <itunes:summary>Confused Drug Names according to ISMP guidelines chart</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/confused-drug-names/article/259474/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Do Not Crush or Chew</title>
            
            
            <description>A list of medications that should not be crushed or chewed.</description>
            
            <link>https://www.empr.com/do-not-crush-or-chew/article/123614/</link>
            <pubDate>Fri, 31 Aug 2018 15:30:00 GMT</pubDate>
            
          <itunes:summary>A list of medications that should not be crushed or chewed.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/do-not-crush-or-chew/article/123614/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Bacterial Conjunctivitis Treatments</title>
            
            
            <description>Bacterial conjunctivitis treatment chart for topical medications.</description>
            
            <link>https://www.empr.com/bacterial-conjunctivitis-treatments/article/123679/</link>
            <pubDate>Thu, 30 Aug 2018 18:30:00 GMT</pubDate>
            
          <itunes:summary>Bacterial conjunctivitis treatment chart for topical medications.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/bacterial-conjunctivitis-treatments/article/123679/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Vaccine Storage and Handling</title>
            
            
            <description>Best practices and recommendations for the appropriate storage and handling of vaccines provided by the CDC.</description>
            
            <link>https://www.empr.com/vaccine-storage-and-handling/article/521242/</link>
            <pubDate>Thu, 30 Aug 2018 16:00:00 GMT</pubDate>
            
          <itunes:summary>Best practices and recommendations for the appropriate storage and handling of vaccines provided by the CDC.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/vaccine-storage-and-handling/article/521242/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Antirheumatic Indications: NSAIDs</title>
            
            
            <description>Includes drugs indicated for different types of arthritis as well as the form and strength the medication is available in.</description>
            
            <link>https://www.empr.com/antirheumatic-indications-nsaids/article/293323/</link>
            <pubDate>Wed, 29 Aug 2018 21:00:00 GMT</pubDate>
            
          <itunes:summary>Includes drugs indicated for different types of arthritis as well as the form and strength the medication is available in.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/antirheumatic-indications-nsaids/article/293323/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Topical Steroid Potencies</title>
            
            
            <description>Topical steroid classification chart sorted by potency.</description>
            
            <link>https://www.empr.com/topical-steroid-potencies/article/123847/</link>
            <pubDate>Tue, 07 Aug 2018 15:00:00 GMT</pubDate>
            
          <itunes:summary>Topical steroid classification chart sorted by potency.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/topical-steroid-potencies/article/123847/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Lice and Scabies Treatments</title>
            
            
            <description>Lice and scabies treatment chart, including pediculicides, scabicides, and lice and nit removal aids.</description>
            
            <link>https://www.empr.com/lice-and-scabies-treatments/article/125863/</link>
            <pubDate>Tue, 07 Aug 2018 13:30:00 GMT</pubDate>
            
          <itunes:summary>Lice and scabies treatment chart, including pediculicides, scabicides, and lice and nit removal aids.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/lice-and-scabies-treatments/article/125863/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Obesity Treatments</title>
            
            
            <description>A comparative list of medications by pharmacological class for the treatment of obesity.</description>
            
            <link>https://www.empr.com/obesity-treatments/article/364238/</link>
            <pubDate>Fri, 03 Aug 2018 20:00:00 GMT</pubDate>
            
          <itunes:summary>A comparative list of medications by pharmacological class for the treatment of obesity.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/obesity-treatments/article/364238/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Drugs Contraindicated in Pregnancy</title>
            
            
            <description>Contraindicated pregnancy medications</description>
            
            <link>https://www.empr.com/drugs-contraindicated-in-pregnancy/article/125914/</link>
            <pubDate>Fri, 03 Aug 2018 19:30:00 GMT</pubDate>
            
          <itunes:summary>Contraindicated pregnancy medications</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/drugs-contraindicated-in-pregnancy/article/125914/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Neuropathic Pain Treatments</title>
            
            
            <description>Chart with medications used to treat neuropathic pain, including diabetic peripheral neuropathy, fibromyalgia, and postherpetic neuralgia.</description>
            
            <link>https://www.empr.com/neuropathic-pain-treatments/article/170630/</link>
            <pubDate>Fri, 03 Aug 2018 19:30:00 GMT</pubDate>
            
          <itunes:summary>Chart with medications used to treat neuropathic pain, including diabetic peripheral neuropathy, fibromyalgia, and postherpetic neuralgia.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/neuropathic-pain-treatments/article/170630/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Anaphylaxis Management</title>
            
            
            <description>Anaphylaxis management for outpatients, inpatients, and patients at discharge.</description>
            
            <link>https://www.empr.com/anaphylaxis-management/article/221237/</link>
            <pubDate>Fri, 03 Aug 2018 17:30:00 GMT</pubDate>
            
          <itunes:summary>Anaphylaxis management for outpatients, inpatients, and patients at discharge.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/anaphylaxis-management/article/221237/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Atherosclerotic Cardiovascular Disease Risk Assessment</title>
            
            
            <description>An assessment to identify adults who may be at high risk for developing atherosclerotic cardiovascular disease (ASCVD).</description>
            
            <link>https://www.empr.com/atherosclerotic-cardiovascular-disease-risk-assessment/article/326682/</link>
            <pubDate>Fri, 03 Aug 2018 17:30:00 GMT</pubDate>
            
          <itunes:summary>An assessment to identify adults who may be at high risk for developing atherosclerotic cardiovascular disease (ASCVD).</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/atherosclerotic-cardiovascular-disease-risk-assessment/article/326682/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Overview of Biologics and Biosimilars</title>
            
            
            <description>Differentiate between biologics and biosimilars including the approval process.</description>
            
            <link>https://www.empr.com/overview-of-biologics-and-biosimilars/article/333128/</link>
            <pubDate>Fri, 03 Aug 2018 17:30:00 GMT</pubDate>
            
          <itunes:summary>Differentiate between biologics and biosimilars including the approval process.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/overview-of-biologics-and-biosimilars/article/333128/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Opioid Equianalgesic Doses</title>
            
            
            <description>Opioid equianalgesic dosing chart used for interchanging between drug, route of administration, or both.</description>
            
            <link>https://www.empr.com/opioid-equianalgesic-doses/article/125879/</link>
            <pubDate>Tue, 24 Jul 2018 13:00:00 GMT</pubDate>
            
          <itunes:summary>Opioid equianalgesic dosing chart used for interchanging between drug, route of administration, or both.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/opioid-equianalgesic-doses/article/125879/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Wound Care Products</title>
            
            
            <description>Wound care dressings and cleansers including hydrocolloid occlusive dressings, wet-to-dry dressings, hydrogels, foam dressings, odor-controlling dressings, and xerogels.</description>
            
            <link>https://www.empr.com/wound-care-products/article/125911/</link>
            <pubDate>Tue, 24 Jul 2018 13:00:00 GMT</pubDate>
            
          <itunes:summary>Wound care dressings and cleansers including hydrocolloid occlusive dressings, wet-to-dry dressings, hydrogels, foam dressings, odor-controlling dressings, and xerogels.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/wound-care-products/article/125911/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Asthma Treatments: Inhalations</title>
            
            
            <description>Inhalation doses for the treatment of asthma and prevention of exercise induced bronchospasm (EIB).</description>
            
            <link>https://www.empr.com/asthma-treatments-inhalations/article/123671/</link>
            <pubDate>Fri, 06 Jul 2018 12:00:00 GMT</pubDate>
            
          <itunes:summary>Inhalation doses for the treatment of asthma and prevention of exercise induced bronchospasm (EIB).</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/asthma-treatments-inhalations/article/123671/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Pharmacological Effects of Grapefruit Juice with Medications</title>
            
            
            <description>Grapefruit Juice and Drug Interaction Chart describing clinical implications of co-administration.</description>
            
            <link>https://www.empr.com/pharmacological-effects-of-grapefruit-juice-with-medications/article/207375/</link>
            <pubDate>Tue, 26 Jun 2018 15:00:00 GMT</pubDate>
            
          <itunes:summary>Grapefruit Juice and Drug Interaction Chart describing clinical implications of co-administration.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/pharmacological-effects-of-grapefruit-juice-with-medications/article/207375/</guid>
               
                                
        </item>
  
        <item>
          
          <title>FDA Codes and Therapeutic Definitions</title>
            
            
            <description>Codes and definitions the FDA uses to determine therapeutic equivalence.</description>
            
            <link>https://www.empr.com/fda-codes-and-therapeutic-definitions/article/123362/</link>
            <pubDate>Tue, 26 Jun 2018 14:30:00 GMT</pubDate>
            
          <itunes:summary>Codes and definitions the FDA uses to determine therapeutic equivalence.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/fda-codes-and-therapeutic-definitions/article/123362/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Muscle Spasm Treatments</title>
            
            
            <description>Muscle spasm treatment chart with dosing regimens for muscle relaxants and other medications.</description>
            
            <link>https://www.empr.com/muscle-spasm-treatments/article/127683/</link>
            <pubDate>Tue, 26 Jun 2018 14:00:00 GMT</pubDate>
            
          <itunes:summary>Muscle spasm treatment chart with dosing regimens for muscle relaxants and other medications.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/muscle-spasm-treatments/article/127683/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Topical Acne Treatments</title>
            
            
            <description>A chart of topical acne medications for the use in children and adults including available strengths.</description>
            
            <link>https://www.empr.com/topical-acne-treatments/article/309258/</link>
            <pubDate>Tue, 26 Jun 2018 13:30:00 GMT</pubDate>
            
          <itunes:summary>A chart of topical acne medications for the use in children and adults including available strengths.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/topical-acne-treatments/article/309258/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hypertension: Beta-Blocker Pharmacokinetics</title>
            
            
            <description>Beta-blocker pharmacokinetics comparison chart for hypertension.</description>
            
            <link>https://www.empr.com/hypertension-beta-blocker-pharmacokinetics/article/221240/</link>
            <pubDate>Tue, 26 Jun 2018 13:00:00 GMT</pubDate>
            
          <itunes:summary>Beta-blocker pharmacokinetics comparison chart for hypertension.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hypertension-beta-blocker-pharmacokinetics/article/221240/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Allergic Conjunctivitis Treatments</title>
            
            
            <description>A comparative dosing chart of prescription and over-the-counter (OTC) medications for allergic conjunctivitis treatment.</description>
            
            <link>https://www.empr.com/allergic-conjunctivitis-treatments/article/123668/</link>
            <pubDate>Tue, 26 Jun 2018 12:00:00 GMT</pubDate>
            
          <itunes:summary>A comparative dosing chart of prescription and over-the-counter (OTC) medications for allergic conjunctivitis treatment.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/allergic-conjunctivitis-treatments/article/123668/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Common Medical Abbreviations</title>
            
            
            <description>Medical abbreviations used by healthcare professionals.</description>
            
            <link>https://www.empr.com/common-medical-abbreviations/article/123360/</link>
            <pubDate>Sun, 24 Jun 2018 20:30:00 GMT</pubDate>
            
          <itunes:summary>Medical abbreviations used by healthcare professionals.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/common-medical-abbreviations/article/123360/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Approximate Practical Equivalents</title>
            
            
            <description>The listing of approximate practical equivalents is included to aid the practitioner in calculating and converting dosages among the various systems.</description>
            
            <link>https://www.empr.com/approximate-practical-equivalents/article/123355/</link>
            <pubDate>Fri, 22 Jun 2018 13:30:00 GMT</pubDate>
            
          <itunes:summary>The listing of approximate practical equivalents is included to aid the practitioner in calculating and converting dosages among the various systems.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/approximate-practical-equivalents/article/123355/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Otic Preparations</title>
            
            
            <description>Otic drug preparations treatment chart for infections, pain, or wax build-up in the ear.</description>
            
            <link>https://www.empr.com/otic-preparations/article/125864/</link>
            <pubDate>Thu, 21 Jun 2018 19:30:00 GMT</pubDate>
            
          <itunes:summary>Otic drug preparations treatment chart for infections, pain, or wax build-up in the ear.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/otic-preparations/article/125864/</guid>
               
                                
        </item>
  
        <item>
          
          <title>FDA-Approved Ovarian Cancer Treatments</title>
            
            
            <description>FDA-Approved treatment options for individuals with ovarian cancer including dosing.</description>
            
            <link>https://www.empr.com/fda-approved-ovarian-cancer-treatments/article/123618/</link>
            <pubDate>Thu, 21 Jun 2018 17:00:00 GMT</pubDate>
            
          <itunes:summary>FDA-Approved treatment options for individuals with ovarian cancer including dosing.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/fda-approved-ovarian-cancer-treatments/article/123618/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Arthritis Treatments: NSAIDs</title>
            
            
            <description>NSAIDS (non-steroidal anti-inflammatory drugs) indicated for the treatment of different types of arthritis.</description>
            
            <link>https://www.empr.com/arthritis-treatments-nsaids/article/190166/</link>
            <pubDate>Wed, 20 Jun 2018 14:30:00 GMT</pubDate>
            
          <itunes:summary>NSAIDS (non-steroidal anti-inflammatory drugs) indicated for the treatment of different types of arthritis.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/arthritis-treatments-nsaids/article/190166/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Error-Prone Dose Designations</title>
            
            
            <description>Error-Prone Dose Designations according to ISMP guidelines</description>
            
            <link>https://www.empr.com/error-prone-dose-designations/article/259475/</link>
            <pubDate>Mon, 11 Jun 2018 19:30:00 GMT</pubDate>
            
          <itunes:summary>Error-Prone Dose Designations according to ISMP guidelines</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/error-prone-dose-designations/article/259475/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Error-Prone Symbols</title>
            
            
            <description>Error-Prone Symbols according to ISMP guidelines</description>
            
            <link>https://www.empr.com/error-prone-symbols/article/253576/</link>
            <pubDate>Mon, 11 Jun 2018 17:00:00 GMT</pubDate>
            
          <itunes:summary>Error-Prone Symbols according to ISMP guidelines</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/error-prone-symbols/article/253576/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Error-Prone Drug Name Abbreviations</title>
            
            
            <description>Error-Prone Drug Name Abbreviations according to ISMP guidelines</description>
            
            <link>https://www.empr.com/error-prone-drug-name-abbreviations/article/253577/</link>
            <pubDate>Mon, 11 Jun 2018 16:00:00 GMT</pubDate>
            
          <itunes:summary>Error-Prone Drug Name Abbreviations according to ISMP guidelines</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/error-prone-drug-name-abbreviations/article/253577/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Error-Prone Abbreviations</title>
            
            
            <description>Error-Prone Abbreviations Chart based on ISMP Guidelines</description>
            
            <link>https://www.empr.com/error-prone-abbreviations/article/253574/</link>
            <pubDate>Mon, 11 Jun 2018 15:00:00 GMT</pubDate>
            
          <itunes:summary>Error-Prone Abbreviations Chart based on ISMP Guidelines</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/error-prone-abbreviations/article/253574/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Common Systems of Weights and Measures</title>
            
            
            <description>Common systems of weights and measures organized by metric system, apothecary system, and avoirdupois system.</description>
            
            <link>https://www.empr.com/common-systems-of-weights-and-measures/article/125882/</link>
            <pubDate>Mon, 11 Jun 2018 14:30:00 GMT</pubDate>
            
          <itunes:summary>Common systems of weights and measures organized by metric system, apothecary system, and avoirdupois system.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/common-systems-of-weights-and-measures/article/125882/</guid>
               
                                
        </item>
  
        <item>
          
          <title>High-Alert Medications</title>
            
            
            <description>High-Alert Medications according to ISMP guidelines</description>
            
            <link>https://www.empr.com/high-alert-medications/article/259476/</link>
            <pubDate>Mon, 11 Jun 2018 14:30:00 GMT</pubDate>
            
          <itunes:summary>High-Alert Medications according to ISMP guidelines</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/high-alert-medications/article/259476/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Initial Prediabetes Conversation: Dos &amp; Don&apos;ts</title>
            
            
            <description>A list of recommended Dos and Don&apos;ts for the initial conversation in patients with prediabetes.</description>
            
            <link>https://www.empr.com/initial-prediabetes-conversation-dos-donts/article/437046/</link>
            <pubDate>Mon, 11 Jun 2018 13:30:00 GMT</pubDate>
            
          <itunes:summary>A list of recommended Dos and Don&apos;ts for the initial conversation in patients with prediabetes.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/initial-prediabetes-conversation-dos-donts/article/437046/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Decision Pathway for Diabetes and Prediabetes</title>
            
            
            <description>An algorithm to help guide the interpretation of blood test results in order to identify patients with prediabetes and prevent the development of diabetes.</description>
            
            <link>https://www.empr.com/decision-pathway-for-diabetes-and-prediabetes/article/439922/</link>
            <pubDate>Mon, 11 Jun 2018 12:30:00 GMT</pubDate>
            
          <itunes:summary>An algorithm to help guide the interpretation of blood test results in order to identify patients with prediabetes and prevent the development of diabetes.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/decision-pathway-for-diabetes-and-prediabetes/article/439922/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Bleeding Disorder Treatments: von Willebrand Disease</title>
            
            
            <description>Treatment options for von Willebrand Disease (VWD).</description>
            
            <link>https://www.empr.com/bleeding-disorder-treatments-von-willebrand-disease/article/772078/</link>
            <pubDate>Fri, 08 Jun 2018 12:20:35 GMT</pubDate>
            
          <itunes:summary>Treatment options for von Willebrand Disease (VWD).</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/bleeding-disorder-treatments-von-willebrand-disease/article/772078/</guid>
               
                                
        </item>
  
        <item>
          
          <title>ADHD Treatments</title>
            
            
            <description>Attention Deficit Hyperactivity Disorder (ADHD) treatment medications comparative chart.</description>
            
            <link>https://www.empr.com/adhd-treatments/article/123669/</link>
            <pubDate>Fri, 25 May 2018 13:30:00 GMT</pubDate>
            
          <itunes:summary>Attention Deficit Hyperactivity Disorder (ADHD) treatment medications comparative chart.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/adhd-treatments/article/123669/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Antipyretic Medications</title>
            
            
            <description>Antipyretics Medications Chart</description>
            
            <link>https://www.empr.com/antipyretic-medications/article/279967/</link>
            <pubDate>Mon, 07 May 2018 16:30:00 GMT</pubDate>
            
          <itunes:summary>Antipyretics Medications Chart</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/antipyretic-medications/article/279967/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Insulin Pen Devices</title>
            
            
            <description>Insulin Pen Devices comparison chart for patients with diabetes mellitus.</description>
            
            <link>https://www.empr.com/insulin-pen-devices/article/170526/</link>
            <pubDate>Mon, 07 May 2018 13:00:00 GMT</pubDate>
            
          <itunes:summary>Insulin Pen Devices comparison chart for patients with diabetes mellitus.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/insulin-pen-devices/article/170526/</guid>
               
                                
        </item>
  
        <item>
          
          <title>PrEP Eligibility Based on HIV Status</title>
            
            
            <description>Determine HIV status and patient&apos;s eligibility for PrEP using this flowchart.</description>
            
            <link>https://www.empr.com/prep-eligibility-based-on-hiv-status/article/385678/</link>
            <pubDate>Fri, 27 Apr 2018 21:30:00 GMT</pubDate>
            
          <itunes:summary>Determine HIV status and patient&apos;s eligibility for PrEP using this flowchart.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/prep-eligibility-based-on-hiv-status/article/385678/</guid>
               
                                
        </item>
  
        <item>
          
          <title>HIV Risk Behavior Assessment</title>
            
            
            <description>Criteria to assess HIV risk behavior in men who have sex with men (MSM), heterosexually active men and women, and injection drug users.</description>
            
            <link>https://www.empr.com/hiv-risk-behavior-assessment/article/368527/</link>
            <pubDate>Fri, 27 Apr 2018 21:00:00 GMT</pubDate>
            
          <itunes:summary>Criteria to assess HIV risk behavior in men who have sex with men (MSM), heterosexually active men and women, and injection drug users.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hiv-risk-behavior-assessment/article/368527/</guid>
               
                                
        </item>
  
        <item>
          
          <title>HIV Pre-Exposure Prophylaxis Algorithm: Men Who Have Sex With Men</title>
            
            
            <description>CDC interim guidance on HIV pre-exposure prophylaxis for men who have sex with men.</description>
            
            <link>https://www.empr.com/hiv-pre-exposure-prophylaxis-algorithm-men-who-have-sex-with-men/article/254509/</link>
            <pubDate>Wed, 25 Apr 2018 19:30:00 GMT</pubDate>
            
          <itunes:summary>CDC interim guidance on HIV pre-exposure prophylaxis for men who have sex with men.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hiv-pre-exposure-prophylaxis-algorithm-men-who-have-sex-with-men/article/254509/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Insomnia and Other Sleep-Wake Disorders</title>
            
            
            <description>Types and characteristics of common sleep-wake disorders.</description>
            
            <link>https://www.empr.com/insomnia-and-other-sleep-wake-disorders/article/123823/</link>
            <pubDate>Mon, 23 Apr 2018 17:00:00 GMT</pubDate>
            
          <itunes:summary>Types and characteristics of common sleep-wake disorders.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/insomnia-and-other-sleep-wake-disorders/article/123823/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Asthma Management: During Pregnancy and Lactation</title>
            
            
            <description>The recommendations for asthma management during pregnancy and lactation are presented in this table.</description>
            
            <link>https://www.empr.com/asthma-management-during-pregnancy-and-lactation/article/123850/</link>
            <pubDate>Thu, 12 Apr 2018 14:00:00 GMT</pubDate>
            
          <itunes:summary>The recommendations for asthma management during pregnancy and lactation are presented in this table.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/asthma-management-during-pregnancy-and-lactation/article/123850/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Respiratory Devices</title>
            
            
            <description>Respiratory devices (spacers, holding chambers, and reservoir bags) used with the treatment of asthma.</description>
            
            <link>https://www.empr.com/respiratory-devices/article/125866/</link>
            <pubDate>Thu, 12 Apr 2018 13:30:00 GMT</pubDate>
            
          <itunes:summary>Respiratory devices (spacers, holding chambers, and reservoir bags) used with the treatment of asthma.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/respiratory-devices/article/125866/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Pharmacological Effects of Alcohol with Medications</title>
            
            
            <description>OTC and prescription medications with potential harmful interactions with alcohol.</description>
            
            <link>https://www.empr.com/pharmacological-effects-of-alcohol-with-medications/article/312707/</link>
            <pubDate>Wed, 11 Apr 2018 19:00:00 GMT</pubDate>
            
          <itunes:summary>OTC and prescription medications with potential harmful interactions with alcohol.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/pharmacological-effects-of-alcohol-with-medications/article/312707/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hypertension Treatment Algorithm</title>
            
            
            <description>Management of hypertension in adults based on evidence-based guidelines.</description>
            
            <link>https://www.empr.com/hypertension-treatment-algorithm/article/123845/</link>
            <pubDate>Wed, 11 Apr 2018 14:30:00 GMT</pubDate>
            
          <itunes:summary>Management of hypertension in adults based on evidence-based guidelines.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hypertension-treatment-algorithm/article/123845/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Pharmacogenetic Considerations for Psychotropic Drugs</title>
            
            
            <description></description>
            
            <link>https://www.empr.com/pharmacogenetic-considerations-for-psychotropic-drugs/article/347671/</link>
            <pubDate>Mon, 09 Apr 2018 17:00:00 GMT</pubDate>
            
          <itunes:summary></itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/pharmacogenetic-considerations-for-psychotropic-drugs/article/347671/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Unintended Pregnancy Percentages by Contraceptive Method</title>
            
            
            <description>Percentage of unintended pregnancies within first year and continued use of various contraceptive methods.</description>
            
            <link>https://www.empr.com/unintended-pregnancy-percentages-by-contraceptive-method/article/300661/</link>
            <pubDate>Fri, 06 Apr 2018 17:30:00 GMT</pubDate>
            
          <itunes:summary>Percentage of unintended pregnancies within first year and continued use of various contraceptive methods.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/unintended-pregnancy-percentages-by-contraceptive-method/article/300661/</guid>
               
                                
        </item>
  
        <item>
          
          <title>2018 Vaccination Schedule: Adults</title>
            
            
            <description>This schedule indicates the recommended age groups and medical indications for routine administration of currently licensed vaccines for persons 19 years and older.</description>
            
            <link>https://www.empr.com/2018-vaccination-schedule-adults/article/123638/</link>
            <pubDate>Mon, 02 Apr 2018 13:00:00 GMT</pubDate>
            
          <itunes:summary>This schedule indicates the recommended age groups and medical indications for routine administration of currently licensed vaccines for persons 19 years and older.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/2018-vaccination-schedule-adults/article/123638/</guid>
               
                                
        </item>
  
        <item>
          
          <title>2018 Vaccination Schedule: 0-18 Years of Age</title>
            
            
            <description>This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines for children 0-18 years of age.</description>
            
            <link>https://www.empr.com/2018-vaccination-schedule-0-18-years-of-age/article/124017/</link>
            <pubDate>Wed, 28 Mar 2018 14:00:00 GMT</pubDate>
            
          <itunes:summary>This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines for children 0-18 years of age.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/2018-vaccination-schedule-0-18-years-of-age/article/124017/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Upper Respiratory Tract Infection Symptoms Comparison</title>
            
            
            <description>Upper Respiratory Tract Infection Symptoms Comparison Chart</description>
            
            <link>https://www.empr.com/upper-respiratory-tract-infection-symptoms-comparison/article/273168/</link>
            <pubDate>Tue, 27 Mar 2018 19:30:00 GMT</pubDate>
            
          <itunes:summary>Upper Respiratory Tract Infection Symptoms Comparison Chart</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/upper-respiratory-tract-infection-symptoms-comparison/article/273168/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Asthma Management: ≥12 Years of Age</title>
            
            
            <description>Asthma management in youths and adults 12 years of age and older classified by asthma severity.</description>
            
            <link>https://www.empr.com/asthma-management-12-years-of-age/article/123677/</link>
            <pubDate>Tue, 27 Mar 2018 19:00:00 GMT</pubDate>
            
          <itunes:summary>Asthma management in youths and adults 12 years of age and older classified by asthma severity.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/asthma-management-12-years-of-age/article/123677/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Asthma Management: 0-4 Years of Age</title>
            
            
            <description>Asthma management chart for children 0-4 years of age.</description>
            
            <link>https://www.empr.com/asthma-management-0-4-years-of-age/article/125871/</link>
            <pubDate>Tue, 27 Mar 2018 19:00:00 GMT</pubDate>
            
          <itunes:summary>Asthma management chart for children 0-4 years of age.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/asthma-management-0-4-years-of-age/article/125871/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Asthma Management: 5-11 Years of Age</title>
            
            
            <description>Asthma management chart for children 5-11 years of age.</description>
            
            <link>https://www.empr.com/asthma-management-5-11-years-of-age/article/125872/</link>
            <pubDate>Tue, 27 Mar 2018 19:00:00 GMT</pubDate>
            
          <itunes:summary>Asthma management chart for children 5-11 years of age.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/asthma-management-5-11-years-of-age/article/125872/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Vaccination Schedule: HIV-Infected 0-6 Years of Age</title>
            
            
            <description>Recommended vaccination schedule for HIV-infected children ages 0 to 6 years old.</description>
            
            <link>https://www.empr.com/vaccination-schedule-hiv-infected-0-6-years-of-age/article/158623/</link>
            <pubDate>Tue, 27 Mar 2018 14:00:00 GMT</pubDate>
            
          <itunes:summary>Recommended vaccination schedule for HIV-infected children ages 0 to 6 years old.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/vaccination-schedule-hiv-infected-0-6-years-of-age/article/158623/</guid>
               
                                
        </item>
  
        <item>
          
          <title>H. pylori Infection Treatment Guideline</title>
            
            
            <description>Recommendations from the ACG Clinical Guideline for the treatment of H. pylori infection.</description>
            
            <link>https://www.empr.com/h-pylori-infection-treatment-guideline/article/123737/</link>
            <pubDate>Thu, 22 Mar 2018 13:00:00 GMT</pubDate>
            
          <itunes:summary>Recommendations from the ACG Clinical Guideline for the treatment of H. pylori infection.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/h-pylori-infection-treatment-guideline/article/123737/</guid>
               
                                
        </item>
  
        <item>
          
          <title>2018 Catch-Up Vaccination Schedule: 4 Months-18 Years</title>
            
            
            <description>A catch-up immunization schedule for children 4 months to 18 years of age, including minimum intervals between doses of delayed immunizations.</description>
            
            <link>https://www.empr.com/2018-catch-up-vaccination-schedule-4-months-18-years/article/125854/</link>
            <pubDate>Tue, 13 Mar 2018 12:30:00 GMT</pubDate>
            
          <itunes:summary>A catch-up immunization schedule for children 4 months to 18 years of age, including minimum intervals between doses of delayed immunizations.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/2018-catch-up-vaccination-schedule-4-months-18-years/article/125854/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hematological Reference Values</title>
            
            
            <description>Reference values for commonly ordered blood tests.</description>
            
            <link>https://www.empr.com/hematological-reference-values/article/123621/</link>
            <pubDate>Tue, 06 Mar 2018 14:00:00 GMT</pubDate>
            
          <itunes:summary>Reference values for commonly ordered blood tests.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hematological-reference-values/article/123621/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hypertension Evaluation</title>
            
            
            <description>Blood pressure classification, diagnostic workup of hypertension, assess for major cardiovascular disease risk factors and identifiable causes, and blood pressure measurement techniques.</description>
            
            <link>https://www.empr.com/hypertension-evaluation/article/123734/</link>
            <pubDate>Mon, 05 Mar 2018 15:00:00 GMT</pubDate>
            
          <itunes:summary>Blood pressure classification, diagnostic workup of hypertension, assess for major cardiovascular disease risk factors and identifiable causes, and blood pressure measurement techniques.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hypertension-evaluation/article/123734/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Pancreatic Enzyme Replacement Therapy</title>
            
            
            <description>Pancreatic enzyme (lipase, pancrease, amylase) replacement therapy comparison chart.</description>
            
            <link>https://www.empr.com/pancreatic-enzyme-replacement-therapy/article/748147/</link>
            <pubDate>Fri, 02 Mar 2018 14:02:15 GMT</pubDate>
            
          <itunes:summary>Pancreatic enzyme (lipase, pancrease, amylase) replacement therapy comparison chart.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/pancreatic-enzyme-replacement-therapy/article/748147/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Medications Disposable by Flushing</title>
            
            
            <description>A list of medications that can be disposed by flushing down the toilet.</description>
            
            <link>https://www.empr.com/medications-disposable-by-flushing/article/427505/</link>
            <pubDate>Tue, 20 Feb 2018 15:00:00 GMT</pubDate>
            
          <itunes:summary>A list of medications that can be disposed by flushing down the toilet.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/medications-disposable-by-flushing/article/427505/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hepatitis B Virus Treatments</title>
            
            
            <description>Hepatitis B Usual Dosing Chart</description>
            
            <link>https://www.empr.com/hepatitis-b-virus-treatments/article/207372/</link>
            <pubDate>Wed, 31 Jan 2018 20:30:00 GMT</pubDate>
            
          <itunes:summary>Hepatitis B Usual Dosing Chart</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hepatitis-b-virus-treatments/article/207372/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hepatitis C Virus Treatment Guidelines</title>
            
            
            <description>Evidence-based treatment guidelines for HCV infection from the expert panel of the AASLD and IDSA.</description>
            
            <link>https://www.empr.com/hepatitis-c-virus-treatment-guidelines/article/207377/</link>
            <pubDate>Wed, 31 Jan 2018 16:30:00 GMT</pubDate>
            
          <itunes:summary>Evidence-based treatment guidelines for HCV infection from the expert panel of the AASLD and IDSA.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hepatitis-c-virus-treatment-guidelines/article/207377/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Osteoporosis Treatments</title>
            
            
            <description>Osteoporosis treatment and prevention doses including recommended calcium and vitamin D supplemental doses.</description>
            
            <link>https://www.empr.com/osteoporosis-treatments/article/123840/</link>
            <pubDate>Wed, 31 Jan 2018 15:00:00 GMT</pubDate>
            
          <itunes:summary>Osteoporosis treatment and prevention doses including recommended calcium and vitamin D supplemental doses.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/osteoporosis-treatments/article/123840/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Atypical Antipsychotic Pharmacokinetics</title>
            
            
            <description>Chart Pharmacokinetics of Atypical Antipsychotics, including Bioavailability, Half-life and CYP 450 Metabolism.</description>
            
            <link>https://www.empr.com/atypical-antipsychotic-pharmacokinetics/article/197025/</link>
            <pubDate>Fri, 12 Jan 2018 19:30:00 GMT</pubDate>
            
          <itunes:summary>Chart Pharmacokinetics of Atypical Antipsychotics, including Bioavailability, Half-life and CYP 450 Metabolism.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/atypical-antipsychotic-pharmacokinetics/article/197025/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Oral and Transdermal Estrogen Dose Equivalents </title>
            
            
            <description>Oral and Transdermal Estrogen Dose Equivalents Chart</description>
            
            <link>https://www.empr.com/oral-and-transdermal-estrogen-dose-equivalents/article/266787/</link>
            <pubDate>Fri, 12 Jan 2018 19:30:00 GMT</pubDate>
            
          <itunes:summary>Oral and Transdermal Estrogen Dose Equivalents Chart</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/oral-and-transdermal-estrogen-dose-equivalents/article/266787/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Pharmacological Migraine Prophylaxis Guidelines</title>
            
            
            <description>Guidelines for pharmacological prophylaxis of migraines chart</description>
            
            <link>https://www.empr.com/pharmacological-migraine-prophylaxis-guidelines/article/244397/</link>
            <pubDate>Fri, 12 Jan 2018 18:00:00 GMT</pubDate>
            
          <itunes:summary>Guidelines for pharmacological prophylaxis of migraines chart</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/pharmacological-migraine-prophylaxis-guidelines/article/244397/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Oral Contraceptives</title>
            
            
            <description>Progestin and estrogen content of oral contraceptives (birth control pills) chart.</description>
            
            <link>https://www.empr.com/oral-contraceptives/article/123837/</link>
            <pubDate>Wed, 10 Jan 2018 22:30:00 GMT</pubDate>
            
          <itunes:summary>Progestin and estrogen content of oral contraceptives (birth control pills) chart.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/oral-contraceptives/article/123837/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Acute Otitis Media Diagnosis and Management</title>
            
            
            <description>Guidelines for the diagnosis and management of acute otitis media in pediatric patients.</description>
            
            <link>https://www.empr.com/acute-otitis-media-diagnosis-and-management/article/347657/</link>
            <pubDate>Tue, 02 Jan 2018 18:00:00 GMT</pubDate>
            
          <itunes:summary>Guidelines for the diagnosis and management of acute otitis media in pediatric patients.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/acute-otitis-media-diagnosis-and-management/article/347657/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Daily Dose Thresholds: Antipsychotics</title>
            
            
            <description>Antipsychotic daily dose threshold chart.</description>
            
            <link>https://www.empr.com/daily-dose-thresholds-antipsychotics/article/123640/</link>
            <pubDate>Tue, 26 Dec 2017 17:00:00 GMT</pubDate>
            
          <itunes:summary>Antipsychotic daily dose threshold chart.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/daily-dose-thresholds-antipsychotics/article/123640/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Blood Glucose Lancing Device and Lancets Compatibility</title>
            
            
            <description>Available lancing devices with their compatible lancets for glucose testing.</description>
            
            <link>https://www.empr.com/blood-glucose-lancing-device-and-lancets-compatibility/article/712739/</link>
            <pubDate>Thu, 07 Dec 2017 21:16:02 GMT</pubDate>
            
          <itunes:summary>Available lancing devices with their compatible lancets for glucose testing.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/blood-glucose-lancing-device-and-lancets-compatibility/article/712739/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Blood Glucose Meter Compatibility with Test Strips</title>
            
            
            <description>Blood Glucose Meter Compatibility with Test Strips chart</description>
            
            <link>https://www.empr.com/blood-glucose-meter-compatibility-with-test-strips/article/125870/</link>
            <pubDate>Thu, 07 Dec 2017 21:00:00 GMT</pubDate>
            
          <itunes:summary>Blood Glucose Meter Compatibility with Test Strips chart</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/blood-glucose-meter-compatibility-with-test-strips/article/125870/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Urinary Incontinence</title>
            
            
            <description>Types of urinary incontinence and its potential causes.</description>
            
            <link>https://www.empr.com/urinary-incontinence/article/125878/</link>
            <pubDate>Wed, 29 Nov 2017 22:30:00 GMT</pubDate>
            
          <itunes:summary>Types of urinary incontinence and its potential causes.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/urinary-incontinence/article/125878/</guid>
               
                                
        </item>
  
        <item>
          
          <title>HIV Postexposure Prophylaxis Algorithm: Sexual Assault</title>
            
            
            <description>Criteria for recommending postexposure prophylaxis (PEP) to HIV following sexual assault</description>
            
            <link>https://www.empr.com/hiv-postexposure-prophylaxis-algorithm-sexual-assault/article/158621/</link>
            <pubDate>Wed, 29 Nov 2017 22:00:00 GMT</pubDate>
            
          <itunes:summary>Criteria for recommending postexposure prophylaxis (PEP) to HIV following sexual assault</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/hiv-postexposure-prophylaxis-algorithm-sexual-assault/article/158621/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Children&apos;s Vitamins</title>
            
            
            <description>Children&apos;s vitamins prescription and over-the-counter (OTC) comparison chart.</description>
            
            <link>https://www.empr.com/childrens-vitamins/article/125868/</link>
            <pubDate>Wed, 25 Oct 2017 12:30:00 GMT</pubDate>
            
          <itunes:summary>Children&apos;s vitamins prescription and over-the-counter (OTC) comparison chart.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/childrens-vitamins/article/125868/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Vaccination Schedule: HIV-Infected Adults</title>
            
            
            <description>Vaccination schedule for HIV-infected adults.</description>
            
            <link>https://www.empr.com/vaccination-schedule-hiv-infected-adults/article/158619/</link>
            <pubDate>Mon, 23 Oct 2017 12:30:00 GMT</pubDate>
            
          <itunes:summary>Vaccination schedule for HIV-infected adults.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/vaccination-schedule-hiv-infected-adults/article/158619/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Daily Dose Thresholds: Sedatives-Hypnotics</title>
            
            
            <description>Sedative-hypnotic medications daily dose threshold chart, especially for long term care patients.</description>
            
            <link>https://www.empr.com/daily-dose-thresholds-sedatives-hypnotics/article/123643/</link>
            <pubDate>Fri, 13 Oct 2017 12:00:00 GMT</pubDate>
            
          <itunes:summary>Sedative-hypnotic medications daily dose threshold chart, especially for long term care patients.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/daily-dose-thresholds-sedatives-hypnotics/article/123643/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Daily Dose Thresholds: Anxiolytics</title>
            
            
            <description>Anxiolytic medications daily dose threshold chart, especially for long term care patients.</description>
            
            <link>https://www.empr.com/daily-dose-thresholds-anxiolytics/article/123642/</link>
            <pubDate>Thu, 12 Oct 2017 12:00:00 GMT</pubDate>
            
          <itunes:summary>Anxiolytic medications daily dose threshold chart, especially for long term care patients.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/daily-dose-thresholds-anxiolytics/article/123642/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Vaccination Schedule: HIV-Infected 7-18 Years of Age</title>
            
            
            <description>Recommended vaccination schedule for HIV-infected children 7 to 18 years old</description>
            
            <link>https://www.empr.com/vaccination-schedule-hiv-infected-7-18-years-of-age/article/158624/</link>
            <pubDate>Tue, 03 Oct 2017 15:30:00 GMT</pubDate>
            
          <itunes:summary>Recommended vaccination schedule for HIV-infected children 7 to 18 years old</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/vaccination-schedule-hiv-infected-7-18-years-of-age/article/158624/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Thromboembolic Disorder Assessment: DVT/PE</title>
            
            
            <description>Risk factors, prevention strategies, signs &amp; symptoms, and general treatment options for deep vein thrombosis (DVT) and pulmonary embolism (PE).</description>
            
            <link>https://www.empr.com/thromboembolic-disorder-assessment-dvtpe/article/219927/</link>
            <pubDate>Tue, 05 Sep 2017 00:00:00 GMT</pubDate>
            
          <itunes:summary>Risk factors, prevention strategies, signs &amp; symptoms, and general treatment options for deep vein thrombosis (DVT) and pulmonary embolism (PE).</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/thromboembolic-disorder-assessment-dvtpe/article/219927/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Smoking Cessation Therapies</title>
            
            
            <description>Smoking cessation therapy regimens of prescription drugs and over-the-counter medications used to help patients quit smoking.</description>
            
            <link>https://www.empr.com/smoking-cessation-therapies/article/123844/</link>
            <pubDate>Fri, 18 Aug 2017 13:00:00 GMT</pubDate>
            
          <itunes:summary>Smoking cessation therapy regimens of prescription drugs and over-the-counter medications used to help patients quit smoking.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/smoking-cessation-therapies/article/123844/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Blood Glucose Meter Comparisons</title>
            
            
            <description>Blood glucose meters comparison chart including injection site, sample size, range, result time, calibration method, memory size, and battery type.</description>
            
            <link>https://www.empr.com/blood-glucose-meter-comparisons/article/125869/</link>
            <pubDate>Tue, 01 Aug 2017 18:00:00 GMT</pubDate>
            
          <itunes:summary>Blood glucose meters comparison chart including injection site, sample size, range, result time, calibration method, memory size, and battery type.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/blood-glucose-meter-comparisons/article/125869/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Oral Allergy Treatments: OTC</title>
            
            
            <description>A comparative dosing chart of over-the-counter (OTC) medications for allergy treatment.</description>
            
            <link>https://www.empr.com/oral-allergy-treatments-otc/article/169357/</link>
            <pubDate>Tue, 25 Jul 2017 13:00:00 GMT</pubDate>
            
          <itunes:summary>A comparative dosing chart of over-the-counter (OTC) medications for allergy treatment.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/oral-allergy-treatments-otc/article/169357/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Fitzpatrick Skin Type Classification</title>
            
            
            <description>The Fitzpatrick Scale classifies patient&apos;s skin type and the ability to burn and tan when exposed to the sun or UV radiation.</description>
            
            <link>https://www.empr.com/fitzpatrick-skin-type-classification/article/294291/</link>
            <pubDate>Tue, 09 May 2017 14:00:00 GMT</pubDate>
            
          <itunes:summary>The Fitzpatrick Scale classifies patient&apos;s skin type and the ability to burn and tan when exposed to the sun or UV radiation.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/fitzpatrick-skin-type-classification/article/294291/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Recommended Indications for PrEP Use</title>
            
            
            <description>Indications for PrEp use in men who have sex with men (MSM), heterosexually active men and women, and injection drug users.</description>
            
            <link>https://www.empr.com/recommended-indications-for-prep-use/article/368526/</link>
            <pubDate>Sun, 30 Apr 2017 14:00:00 GMT</pubDate>
            
          <itunes:summary>Indications for PrEp use in men who have sex with men (MSM), heterosexually active men and women, and injection drug users.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/recommended-indications-for-prep-use/article/368526/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Prenatal Vitamins Without DHA</title>
            
            
            <description>A table of prenatal vitamins that do not contain DHA including vitamin and mineral content for each vitamin.</description>
            
            <link>https://www.empr.com/prenatal-vitamins-without-dha/article/329230/</link>
            <pubDate>Mon, 27 Feb 2017 14:00:00 GMT</pubDate>
            
          <itunes:summary>A table of prenatal vitamins that do not contain DHA including vitamin and mineral content for each vitamin.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/prenatal-vitamins-without-dha/article/329230/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Prenatal Vitamins With DHA</title>
            
            
            <description>A table of prenatal vitamins that contain DHA including vitamin and mineral content for each vitamin.</description>
            
            <link>https://www.empr.com/prenatal-vitamins-with-dha/article/125903/</link>
            <pubDate>Fri, 24 Feb 2017 15:30:00 GMT</pubDate>
            
          <itunes:summary>A table of prenatal vitamins that contain DHA including vitamin and mineral content for each vitamin.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/prenatal-vitamins-with-dha/article/125903/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Controlled Substance Schedules</title>
            
            
            <description>Schedules of Controlled Substances categorized by the FDA.</description>
            
            <link>https://www.empr.com/controlled-substance-schedules/article/123363/</link>
            <pubDate>Tue, 02 Dec 2014 16:00:00 GMT</pubDate>
            
          <itunes:summary>Schedules of Controlled Substances categorized by the FDA.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/controlled-substance-schedules/article/123363/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Dosages for the Elderly</title>
            
            
            <description>Dosing considerations for elderly patients: renal function, drug severity, drug distribution, polypharmacy, and hepatic function.</description>
            
            <link>https://www.empr.com/dosages-for-the-elderly/article/125906/</link>
            <pubDate>Tue, 02 Dec 2014 16:00:00 GMT</pubDate>
            
          <itunes:summary>Dosing considerations for elderly patients: renal function, drug severity, drug distribution, polypharmacy, and hepatic function.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/dosages-for-the-elderly/article/125906/</guid>
               
                                
        </item>
  
        <item>
          
          <title>FDA Pregnancy Categories</title>
            
            
            <description>Chart showing pregnancy categories are assigned to drugs to define their risk of causing fetal harm during pregnancy. There are five pregnancy categories (A, B, C, D, and X).</description>
            
            <link>https://www.empr.com/fda-pregnancy-categories/article/125913/</link>
            <pubDate>Tue, 02 Dec 2014 16:00:00 GMT</pubDate>
            
          <itunes:summary>Chart showing pregnancy categories are assigned to drugs to define their risk of causing fetal harm during pregnancy. There are five pregnancy categories (A, B, C, D, and X).</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/fda-pregnancy-categories/article/125913/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Liver Function Assessment</title>
            
            
            <description>Child Pugh Score liver function assessment chart for cirrhosis patients.</description>
            
            <link>https://www.empr.com/liver-function-assessment/article/125909/</link>
            <pubDate>Fri, 29 Aug 2014 11:00:00 GMT</pubDate>
            
          <itunes:summary>Child Pugh Score liver function assessment chart for cirrhosis patients.</itunes:summary>
          <itunes:author><![CDATA[MPR]]></itunes:author>
            
            
            
            <guid>https://www.empr.com/liver-function-assessment/article/125909/</guid>
               
                                
        </item>
  
      </channel>
    </rss>  
  